Eprex and Appetite - increased - a phase IV clinical study of FDA data

Summary:

Appetite - increased is reported as a side effect among people who take Eprex (epoetin alfa), especially for people who are female, 60+ old, also take Calcium, and have Primary myelofibrosis.

The phase IV clinical study analyzes which people have Appetite - increased when taking Eprex. It is created by eHealthMe based on reports of 5,531 people who have side effects when taking Eprex from the FDA, and is updated regularly.

What is Eprex?

Eprex has active ingredients of epoetin alfa. eHealthMe is studying from 5,554 Eprex users. Check the latest studies of Eprex.

What is Appetite - increased?

Appetite - increased (increased appetite is when you want to eat much more often or in larger quantities than your body requires) is found to be associated with 1,567 drugs and 2,031 conditions by eHealthMe. Check the latest studies of Appetite - increased.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

5,531 people reported to have side effects when taking Eprex.
Among them, 16 people (0.29%) have Appetite - increased.

Among these 16 people:

What is the gender of people who have Appetite - increased when taking Eprex? *

female: 90.91 %
male: 9.09 %

What is the age of people who have Appetite - increased when taking Eprex? *

What are other drugs people take besides Eprex? *

What are other side effects people have besides Appetite - increased? *

Weight Increased: 16 people, 100.00%
The Flu (the flu is caused by an influenza virus): 11 people, 68.75%
Nasopharyngitis (inflammation of the nasopharynx): 10 people, 62.50%
Therapeutic Response Decreased (less preventive response): 9 people, 56.25%
Weight Decreased: 8 people, 50.00%
Urinary Tract Infection: 7 people, 43.75%
Haemoglobin Decreased: 7 people, 43.75%
Pleural Effusion (water on the lungs): 6 people, 37.50%
Escherichia Sepsis (bacterial infection by escherichia coli): 6 people, 37.50%
Haemorrhoidal Haemorrhage (bleeding from the haemorrhoids): 6 people, 37.50%

What are the existing conditions these people have? *

Primary Myelofibrosis (primary disorder of the bone marrow): 7 people, 43.75%
Iron Overload: 6 people, 37.50%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 5 people, 31.25%
Generalised Oedema (swelling all over the body): 5 people, 31.25%
Enterococcal Infection: 5 people, 31.25%
Polycythaemia Vera (blood disorder in which the bone marrow makes too many red blood cells): 2 people, 12.50%
Thyroid Diseases: 1 person, 6.25%
Multiple Myeloma (cancer of the plasma cells): 1 person, 6.25%
Breast Cancer: 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Eprex and have Appetite - increased?

- Check whether Appetite - increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Eprex:

Eprex (5,554 reports)

Browse all side effects of Eprex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Appetite - increased:

Appetite - increased (1,567 drugs)

Browse all the conditions that are associated with Appetite - increased:

Appetite - increased (2,031 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on epoetin alfa (the active ingredients of Eprex) and Eprex (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.